In reply to: Questioning the ethics of ethicists
Access status:
Open Access
Type
Article, LetterAbstract
Hamor questions ‘the ethics of the ethicists’ without addressing the substantive points made in our paper.1 While our empirical findings were that physicians and members of the public consider that some gifts are appropriate, we go further and explore the implications of those ...
See moreHamor questions ‘the ethics of the ethicists’ without addressing the substantive points made in our paper.1 While our empirical findings were that physicians and members of the public consider that some gifts are appropriate, we go further and explore the implications of those findings.2 Just as a public survey finding support for capital punishment would not be sufficient to convince us that it was right, we argue that pharmaceutical industry largesse should not be accepted simply because it enjoys popular or professional support. Data are important, but are not the only consideration. Values, including the independence of clinical decision making and the primacy of patient welfare, should also be considered. These are accepted ethical commitments within the profession. For these reasons, we question pharmaceutical marketing and the use of ‘gifts’ to influence doctors' prescribing. There is concern in the literature about the potential for this strategy to bias doctors' judgments. The giving of ‘gifts’ to doctors has the intended outcome that doctors prescribe from loyalty to the ‘gift’ giver rather than prescribing on the basis of evidence of drug efficacy and safety. Even a small gift like ‘post-it’ notes can have this effect. Hamor, however, appears to argue that acceptance of gifts from industry is not morally problematic without addressing the primary concern that this may undermine the independence of clinical decision making and potentially put patients at risk.
See less
See moreHamor questions ‘the ethics of the ethicists’ without addressing the substantive points made in our paper.1 While our empirical findings were that physicians and members of the public consider that some gifts are appropriate, we go further and explore the implications of those findings.2 Just as a public survey finding support for capital punishment would not be sufficient to convince us that it was right, we argue that pharmaceutical industry largesse should not be accepted simply because it enjoys popular or professional support. Data are important, but are not the only consideration. Values, including the independence of clinical decision making and the primacy of patient welfare, should also be considered. These are accepted ethical commitments within the profession. For these reasons, we question pharmaceutical marketing and the use of ‘gifts’ to influence doctors' prescribing. There is concern in the literature about the potential for this strategy to bias doctors' judgments. The giving of ‘gifts’ to doctors has the intended outcome that doctors prescribe from loyalty to the ‘gift’ giver rather than prescribing on the basis of evidence of drug efficacy and safety. Even a small gift like ‘post-it’ notes can have this effect. Hamor, however, appears to argue that acceptance of gifts from industry is not morally problematic without addressing the primary concern that this may undermine the independence of clinical decision making and potentially put patients at risk.
See less
Date
2010-01-01Publisher
WileyCitation
Macneill P, Kerridge I, Newby D, Stokes B, Doran E, Henry D. In reply to: Questioning the ethics of ethicists. Intern Med J. 2010; 40(11):799-80.Share